The long and winding road for selective androgen receptor modulators

Area of Science:

• Pharmacology
• Endocrinology
• Muscle Physiology

Background:

• Selective androgen receptor modulators (SARMs) have shown promise in increasing lean body mass.
• These compounds exhibit favorable pharmacological and pharmacokinetic profiles and are generally well-tolerated.
• A clear link between SARM-induced lean mass gains and functional improvements in patients has not been definitively established.

Purpose of the Study:

• To explore the relationship between lean body mass and physical function in a large patient population treated with SARMs.
• To address the elusive demonstration of functional benefits derived from SARM therapy.
• To provide insights into the evolving landscape of clinical endpoints for SARM approval.

Main Methods:

• The abstract does not specify the methods used.
• Further research is needed to define the methodologies for demonstrating physical function linkage.
• Analysis of existing and future clinical trial data is implied.

Main Results:

• SARMs effectively increase lean body mass in humans.
• The definitive linkage between increased lean body mass and enhanced physical function in large patient populations is yet to be demonstrated.
• Clinical endpoints for SARM approval are dynamic and subject to change.

Conclusions:

• While SARMs can increase lean body mass, their impact on physical function requires further robust clinical validation.
• The evolving nature of clinical endpoints highlights the need for comprehensive safety and efficacy data.
• Future research should focus on establishing clear functional benefits to guide SARM development and regulatory approval.